- Home
- SCHL vs OLMA Comparison
SCHL vs OLMA Comparison
Compare SCHL & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCHL | OLMA |
|---|---|---|
| Founded | 1920 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Books | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.7M | 725.5M |
| IPO Year | 1987 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SCHL | OLMA |
|---|---|---|
| Price | $28.99 | $35.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $37.00 | ★ $40.50 |
| AVG Volume (30 Days) | 252.1K | ★ 8.5M |
| Earning Date | 12-18-2025 | 11-10-2025 |
| Dividend Yield | ★ 2.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,613,900,000.00 | N/A |
| Revenue This Year | $3.78 | N/A |
| Revenue Next Year | $4.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.97 | N/A |
| 52 Week Low | $15.77 | $2.86 |
| 52 Week High | $31.86 | $33.50 |
Technical Indicators
Market Signals| Indicator | SCHL | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 85.40 |
| Support Level | $27.08 | $25.62 |
| Resistance Level | $29.47 | $33.50 |
| Average True Range (ATR) | 1.03 | 2.33 |
| MACD | -0.02 | 0.43 |
| Stochastic Oscillator | 42.05 | 97.45 |
Price Performance
Historical ComparisonAbout SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.